AN INVIVO MODEL FOR THE NEURODEGENERATIVE EFFECTS OF BETA-AMYLOID AND PROTECTION BY SUBSTANCE-P

被引:548
作者
KOWALL, NW
BEAL, MF
BUSCIGLIO, J
DUFFY, LK
YANKNER, BA
机构
[1] CHILDRENS HOSP MED CTR,DEPT NEUROL,ENDERS 260,300 LONGWOOD AVE,BOSTON,MA 02115
[2] MASSACHUSETTS GEN HOSP,DEPT NEUROL,BOSTON,MA 02114
[3] UNIV ALASKA,DEPT CHEM,FAIRBANKS,AK 99775
关键词
ALZHEIMER DISEASE; NEUROTOXIN; CYTOSKELETON; TACHYKININ;
D O I
10.1073/pnas.88.16.7247
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Deposition of the beta-amyloid protein in senile plaques is a pathologic hallmark of Alzheimer disease (AD). Focal deposition of beta-amyloid in the adult rat cerebral cortex caused profound neurodegenerative changes, including neuronal loss and degenerating neurons and neurites. Chronic induction of the Alz-50 antigen appeared in neurons around focal cortical deposits of beta-amyloid. Immunoblot analysis showed that beta-amyloid induced Alz-50-immunoreactive proteins in rat cerebral cortex that were very similar to the proteins induced in human cerebral cortex from patients with AD. The neuropeptide substance P prevented beta-amyloid-induced neuronal loss and expression of Alz-50 proteins when coadministered into the cerebral cortex. Systemic administration of substance P also provided protection against the effects of intracerebral beta-amyloid. Thus, beta-amyloid is a potent neurotoxin in the adult brain in vivo, and its effects can be blocked by substance P.
引用
收藏
页码:7247 / 7251
页数:5
相关论文
共 30 条
[1]  
Alzheimer A., 1907, ALLG Z PSYCHIATR PS, V64, P146, DOI DOI 10.1002/CA.980080612
[2]   PEPTIDES AND THE BLOOD-BRAIN-BARRIER - LIPOPHILICITY AS A PREDICTOR OF PERMEABILITY [J].
BANKS, WA ;
KASTIN, AJ .
BRAIN RESEARCH BULLETIN, 1985, 15 (03) :287-292
[3]   SUBSTANCE-P-LIKE IMMUNOREACTIVITY IS REDUCED IN ALZHEIMERS-DISEASE CEREBRAL-CORTEX [J].
BEAL, MF ;
MAZUREK, MF .
NEUROLOGY, 1987, 37 (07) :1205-1209
[4]  
BEAL MF, 1991, NEUROSCIENCE, V11, P147
[5]  
BOURAS C, 1990, Alzheimer Disease and Associated Disorders, V4, P24, DOI 10.1097/00002093-199040100-00003
[6]   CORTICAL SUBSTANCE P-LIKE IMMUNOREACTIVITY IN CASES OF ALZHEIMERS-DISEASE AND SENILE DEMENTIA OF THE ALZHEIMER TYPE [J].
CRYSTAL, HA ;
DAVIES, P .
JOURNAL OF NEUROCHEMISTRY, 1982, 38 (06) :1781-1784
[7]   DOES AMYLOID PRECEDE PAIRED HELICAL FILAMENTS IN THE SENILE PLAQUE - A STUDY OF 15 CASES WITH GRADED INTELLECTUAL STATUS IN AGING AND ALZHEIMER-DISEASE [J].
DUYCKAERTS, C ;
DELAERE, P ;
POULAIN, V ;
BRION, JP ;
HAUW, JJ .
NEUROSCIENCE LETTERS, 1988, 91 (03) :354-359
[8]   GOLGI-LIKE DEMONSTRATION OF DARK NEURONS WITH AN ARGYROPHIL-III METHOD FOR EXPERIMENTAL NEUROPATHOLOGY [J].
GALLYAS, F ;
GULDNER, FH ;
ZOLTAY, G ;
WOLFF, JR .
ACTA NEUROPATHOLOGICA, 1990, 79 (06) :620-628
[9]   DOWN PATIENTS - EXTRACELLULAR PREAMYLOID DEPOSITS PRECEDE NEURITIC DEGENERATION AND SENILE PLAQUES [J].
GIACCONE, G ;
TAGLIAVINI, F ;
LINOLI, G ;
BOURAS, C ;
FRIGERIO, L ;
FRANGIONE, B ;
BUGIANI, O .
NEUROSCIENCE LETTERS, 1989, 97 (1-2) :232-238
[10]   ALZHEIMERS-DISEASE - INITIAL REPORT OF THE PURIFICATION AND CHARACTERIZATION OF A NOVEL CEREBROVASCULAR AMYLOID PROTEIN [J].
GLENNER, GG ;
WONG, CW .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1984, 120 (03) :885-890